Parallax Volatility Advisers’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-17,000
Closed -$842K 2972
2020
Q3
$842K Buy
17,000
+1,000
+6% +$51.6K ﹤0.01% 2052
2020
Q2
$764K Buy
16,000
+1,000
+7% +$48.2K ﹤0.01% 1836
2020
Q1
$638K Buy
+15,000
New +$741K ﹤0.01% 1629
2017
Q4
Sell
-9,300
Closed -$276K 4311
2017
Q3
$276K Buy
+9,300
New +$284K ﹤0.01% 1388

Other funds holding GMED

Parallax Volatility Advisers's GMED Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 2,310 shares — an estimated $114K sold.

Parallax Volatility Advisers first reported a position in GMED in Q3 2017 and held it in 8 quarters. The position peaked at $446K in Q4 2017. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,310 Globus Medical shares in Q4 2020, an estimated $114K.
  • Parallax Volatility Advisers first reported a position in Globus Medical in Q3 2017 and held it in 8 quarters.
  • Parallax Volatility Advisers's Globus Medical position peaked at $446K in Q4 2017.
  • 348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.